(Q36651026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

triple-negative breast cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Magdalena Murawska

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Tadeusz Pieńkowski

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

2

Anna Niwińska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

5 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

21 February 2020

copyright license

start time

5 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Triple negative breast cancer - prognostic factors and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Factors associated with mortality after breast cancer metastasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Triple-negative breast cancer in Lebanon: a case series

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Deconstructing the molecular portraits of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Metastatic behavior of breast cancer subtypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Survival among women with triple receptor-negative breast cancer and brain metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Triple-negative breast cancer: clinical features and patterns of recurrence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

Impact of triple negative phenotype on breast cancer prognosis

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

Is triple negative a prognostic factor in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

The prognostic importance of triple negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

Clinical relevance of TNM staging system according to breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0388-4

Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586394

10.1007/S12032-012-0388-4

20 September 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

23292831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292831%20AND%20SRC:MED&resulttype=core&format=json